Alan F Holmer - Net Worth and Insider Trading

Alan F Holmer Net Worth

The estimated net worth of Alan F Holmer is at least $35,265 dollars as of 2024-06-06. Alan F Holmer is the Director of Corbus Pharmaceuticals Holdings Inc and owns about 750 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) stock worth over $35,265. Details can be seen in Alan F Holmer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alan F Holmer has not made any transactions after 2017-05-11 and currently still holds the listed stock(s).

Transaction Summary of Alan F Holmer

To

Alan F Holmer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan F Holmer owns 1 companies in total, including Corbus Pharmaceuticals Holdings Inc (CRBP) .

Click here to see the complete history of Alan F Holmer’s form 4 insider trades.

Insider Ownership Summary of Alan F Holmer

Ticker Comapny Transaction Date Type of Owner
CRBP Corbus Pharmaceuticals Holdings Inc 2017-05-11 director

Alan F Holmer Latest Holdings Summary

Alan F Holmer currently owns a total of 1 stock. Alan F Holmer owns 750 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) as of May 11, 2017, with a value of $35,265.

Latest Holdings of Alan F Holmer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRBP Corbus Pharmaceuticals Holdings Inc 2017-05-11 750 47.02 35,265

Holding Weightings of Alan F Holmer


Alan F Holmer Form 4 Trading Tracker

According to the SEC Form 4 filings, Alan F Holmer has made a total of 0 transactions in Corbus Pharmaceuticals Holdings Inc (CRBP) over the past 5 years. The most-recent trade in Corbus Pharmaceuticals Holdings Inc is the acquisition of 17 shares on May 11, 2017, which cost Alan F Holmer around $3,115.

Insider Trading History of Alan F Holmer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alan F Holmer Trading Performance

GuruFocus tracks the stock performance after each of Alan F Holmer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan F Holmer is -0.51%. GuruFocus also compares Alan F Holmer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan F Holmer within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alan F Holmer's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alan F Holmer

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.01 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.39 LIMIT LIMIT LIMIT LIMIT LIMIT

Alan F Holmer Ownership Network

Ownership Network List of Alan F Holmer

No Data

Ownership Network Relation of Alan F Holmer

Insider Network Chart

Alan F Holmer Owned Company Details

What does Corbus Pharmaceuticals Holdings Inc do?

Who are the key executives at Corbus Pharmaceuticals Holdings Inc?

Alan F Holmer is the director of Corbus Pharmaceuticals Holdings Inc. Other key executives at Corbus Pharmaceuticals Holdings Inc include Chief Financial Officer Sean F. Moran , director & Chief Executive Officer Yuval Cohen , and Chief Commercial Officer Craig Stuart Millian .

Corbus Pharmaceuticals Holdings Inc (CRBP) Insider Trades Summary

Over the past 18 months, Alan F Holmer made no insider transaction in Corbus Pharmaceuticals Holdings Inc (CRBP). Other recent insider transactions involving Corbus Pharmaceuticals Holdings Inc (CRBP) include a net purchase of 1,032,632 shares made by Cormorant Global Healthcare Master Fund, Lp , and a net purchase of 550,000 shares made by Cormorant Asset Management, Lp .

In summary, during the past 3 months, insiders sold 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) in total and bought 550,000 shares, with a net purchase of 550,000 shares. During the past 18 months, 0 shares of Corbus Pharmaceuticals Holdings Inc (CRBP) were sold and 1,582,632 shares were bought by its insiders, resulting in a net purchase of 1,582,632 shares.

Corbus Pharmaceuticals Holdings Inc (CRBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Corbus Pharmaceuticals Holdings Inc Insider Transactions

No Available Data

Alan F Holmer Mailing Address

Above is the net worth, insider trading, and ownership report for Alan F Holmer. You might contact Alan F Holmer via mailing address: C/o Corbus Pharmaceuticals Holdings, Inc, 100 River Ridge Drive, Norwood Ma 02062.

Discussions on Alan F Holmer

No discussions yet.